RT @WACIHealth: Proud to join @PATHtweets & @UNITAID on the #MADEinAfrica initiative to strengthen diagnostic manufacturing capacity in Af….

RT @Medic: Good data = stronger #proCHW programs 💡. That’s why we’re excited to share @join_chic's new guide on #data best practice. It wa….

How can countries build health systems that work for everyone? At @Evi4DevCon, PATH’s Melissa Wanda discussed Kenya’s 2023 health reforms, showing how community-centered policies can make accessible health care a reality for millions. Read in @HealthBizKE:

We are excited to be in Nairobi this week with @africanmedtech, spotlighting medtech innovation & sharing insights on regulation, investment & scaling impact. Learn more: #TAMC2025 #TAMCPartner

Make America Fentanyl Free supports President Trump’s efforts to end the fentanyl crisis.

RT @PATHdrugdev: Last week at #COINN2025, @PATHtweets & civil society partners highlighted Zambia's #oxygen CSO coalition—who advocate for….

We’re entering a new phase in #malaria prevention—but scaling impact requires overcoming challenges in policy, financing & delivery. Join us for this #PATHLiveForum on chemoprevention, supported by a @GSK unrestricted educational grant: #WorldMosquitoDay

In @asteriskmgzn, @PriyankaPulla writes about @SerumInstIndia—"the largest, and generally most affordable, supplier of #vaccines around the world." Together, PATH & Serum have developed low-cost vaccines for some of the deadliest diseases in LMICs:

MADE in Africa is a new $11M initiative w/ @UNITAID to boost regional diagnostic manufacturing. With @ASLM_News, @SCIDaR_ , @UCT_news, @WACIHealth & @OCA_Africa, we’ll strengthen supply chains & support African manufacturers in making high-quality tests.

RT @AU_ECOSOCC: Ever heard of the Lusaka Agenda?!. It’s Africa saying:.❌ We can’t keep relying on outsiders to pay for our healthcare. ✅ We….

RT @UNITAID: Africa imports 95%+ of its pharmaceutical ingredients. With @EU_Commission funding, Unitaid, @PATHtweets & @uspharmacopeia are….

RT @c4ir_rw: 📢A pioneering non-interventional research trial in #Rwanda is assessing how an AI knowledge assistant can help CHWs better tri….

Treating P. vivax #malaria is risky for people with G6PD deficiency. Without testing, treatment isn’t safe. We helped develop a low-cost, 2-min blood test—the first @WHO-prequalified point-of-care test for G6PD—to enable safe treatment in low-resource settings. #WorldMosquitoDay

RT @Kate_L_OBrien: A proud moment for public health in Guinea: the #malaria vaccine is now part of routine immunization—protecting thousand….

The August edition of PATH Insights is out now 🌱 This month, we highlight some of the new ways PATH is working to ensure #HopefulFutures for mothers and children. Read now + subscribe to get the next issue in your inbox:

RT @gavi: Congratulations Guinea for becoming the 21st African country to launch malaria vaccines! We’re proud to join our partners @WHO, @….

Tune into the upcoming Global Onchocerciasis Network for Elimination webinar on August 19! PATH's William Sheahan will present on the @WHO- and @gatesfoundation-funded toolkit for integrated post-validation surveillance of #NTDs. Register here:

📢 To sustain and accelerate immunization progress, Africa must invest more and invest now. New resources from PATH, @GaviCSO & @WACIHealth present findings from an #ImmunizationFinancing study & share recommendations for CSOs, donors & decision-makers:

RT @InterActionOrg: U.S. foreign aid cuts are depleting @UNICEF's RUTF stocks. RUTFs, or ready-to-use therapeutic foods, are energy-dense….

RT @CDFUUG: Successful #immunization isn't just about vaccines, it's about access & information. We are participating in the Schools & Heal….

10+ years of collaboration with @GHITFund! Our Global Head of Bacterial & Parasitic Diseases Ashley Birkett shares some highlights and underscores the importance of diverse funding & partnerships in #GlobalHealth 👇.